<DOC>
	<DOCNO>NCT02233192</DOCNO>
	<brief_summary>The purpose study observe patient response current clinical practice utilize TRUVADA ( emtricitabine tenofovir disoproxil fumarate ) Pre-Exposure Prophylaxis ( PrEP ) amongst HIV serodiscordant couple desire conceive across four U.S. city currently offer method standard care . This study observational cohort study , test feasibility acceptability PrEP conception , examine challenge generalizability current medical practice . The CDC recently release formal clinical practice guideline use PrEP United States . For high-risk serodiscordant heterosexual couple use PrEP conception , guideline state , `` PrEP use periconception pregnancy uninfected partner may offer additional tool reduce risk sexual HIV acquisition . Both FDA label information perinatal antiretroviral treatment guideline permit use '' ( CDC 2014 ) .</brief_summary>
	<brief_title>PrEPception : Expanding Assisted Reproductive Options Serodiscordant Couples</brief_title>
	<detailed_description>Based CDC 's guidance PrEP well result randomize controlled trial , U.S. Food Drug Administration ( FDA ) approve daily medication ( comprised one pill ) reduce risk sexually acquire HIV adult high risk . Other medical practice avoid transmission within population include assist reproductive technology sperm wash ( donated sperm ) couple vitro fertilization , intracytoplasmic sperm injection ( vitro procedure single sperm inject directly egg ) , intrauterine insemination ( place sperm directly uterus ) . However , method costly often regionally scarce . PrEP accessible less expensive option couple . When use consistently prescribe , PrEP show significantly reduce risk HIV infection among adult men woman . However , risk reduction counsel clinical monitoring necessary effective implementation . Therefore , beyond efficacy trial , important conduct additional study pre-exposure prophylaxis observe factor make PrEP feasible acceptable couple , well identify factor impact level adherence . The study take place four U.S. city : Boston , Baltimore , Philadelphia , San Francisco involve couple choose begin PrEP conception part clinical care receive preconception counsel review option health care provider .</detailed_description>
	<criteria>Between age 18 40 year In relationship HIVpositive male Chosen take PrEP conception complete counsel health care provider HIVpositive In relationship HIVnegative female Partner chosen take PrEP conception complete counsel health care provider</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PrEP</keyword>
	<keyword>conception</keyword>
	<keyword>HIV</keyword>
	<keyword>serodiscordant</keyword>
</DOC>